OpenVSafe by OpenVAERS
Search V-safe

V7M-13407-64158

3 vaccinations 10 coded responses 31 check-ins 10 free-text entries 0 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
837 / ID
Registered
2021-01-07
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
DMJ-32853-11624 Child or adolescent in my care · Female · 2021-12-10
LC5-27273-86344 Child or adolescent in my care · Male · 2021-12-10
FDT-17841-82571 Child or adolescent in my care · Female · 2022-01-01

Timeline

  1. 2020-12-27
    Dose 1 — Moderna
  2. 2021-01-07
    Registered in v-safe
  3. 2021-01-07
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-10
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  5. 2021-01-17
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  6. 2021-01-24
    Health check-in — day 28, dose 1
    Feeling: Good
    Adult check-in
  7. 2021-01-26
    Dose 2 — Moderna
  8. 2021-01-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work
    Adult check-in
  9. 2021-01-28
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness
    Free text: Large supraclavicular lymph node on same side as vaccine
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-01-29
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Swollen lymph nodes on left supraclavicular area
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-01-31
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Swollen lymph nodes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-02-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-02-02
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-02-09
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-02-16
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-02-23
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-03-02
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-03-09
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-04-27
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-07-27
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-12-09
    Dose 3 — Pfizer-BioNTech
  22. 2021-12-10
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness, Nausea
    Free text: Swollen supraclavicular lymph node
    MedDRA releases: 2024-11 · check-in free text available
  23. 2021-12-11
    Survey response — days 1–6 daily, dose 3
    MedDRA: Axillary pain, Hyperhidrosis, Lymphadenopathy, Night sweats, Oedema peripheral — Feeling: Fair · Site: Pain
    Free text: Drenching night sweat, persistent supraclavicular lymphadenopathy and sore axillary swelling
    MedDRA releases: 2024-11 · check-in free text available
  24. 2021-12-12
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Headache, Fatigue or tiredness
    Free text: Painful swollen lymph nodes
    MedDRA releases: 2024-11 · check-in free text available
  25. 2021-12-13
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good
    Free text: Painful swollen supraclavicular lymph node
    MedDRA releases: 2024-11 · check-in free text available
  26. 2021-12-15
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  27. 2021-12-16
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  28. 2021-12-24
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  29. 2021-12-30
    Survey response — day 21, dose 3
    MedDRA: Upper respiratory tract infection — Feeling: Good
    Free text: Mild URI
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-01-07
    Survey response — day 28, dose 3
    MedDRA: Nasal congestion, Rhinorrhoea, Viral upper respiratory tract infection — Feeling: Good
    Free text: Viral URI. Nasal congestion and runny nose x 5 days.
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-01-13
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  32. 2022-01-20
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  33. 2022-03-10
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  34. 2022-06-09
    Survey response — 6 months, dose 3
    MedDRA: COVID-19, Laryngitis, Viral upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Viral URI currently with laryngitis. Had COVID in April
    MedDRA releases: 2024-11 · check-in free text available
  35. 2022-12-09
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-27Moderna
22021-01-26Moderna
32021-12-09Pfizer-BioNTech No

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-28

Systemic reaction (other): Large supraclavicular lymph node on same side as vaccine

Release 3 — days 1–6 daily, dose 2

2021-01-29

Systemic reaction (other): Swollen lymph nodes on left supraclavicular area

2021-01-31

Systemic reaction (other): Swollen lymph nodes

Release 10 — days 1–6 daily, dose 3

2021-12-10

Systemic reaction (other): Swollen supraclavicular lymph node

2021-12-11

Systemic reaction (other): Drenching night sweat, persistent supraclavicular lymphadenopathy and sore axillary swelling

2021-12-12

Systemic reaction (other): Painful swollen lymph nodes

2021-12-13

Systemic reaction (other): Painful swollen supraclavicular lymph node

Release 10 — day 21, dose 3

2021-12-30

Symptoms: Mild URI

Release 10 — day 28, dose 3

2022-01-07

Symptoms: Viral URI. Nasal congestion and runny nose x 5 days.

Release 12 — 6 months, dose 3

2022-06-09

Symptoms: Viral URI currently with laryngitis. Had COVID in April

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDLaryngitis · · ✓
SDNasal congestion · · ✓
SDRhinorrhoea · · ✓
SDUpper respiratory tract infection · · ✓
SDViral upper respiratory tract infection · · ✓
SROAxillary pain · · ✓
SROHyperhidrosis · · ✓
SROLymph node pain · · ✓
SROLymphadenopathy ✓ ✓ ✓
SRONight sweats · · ✓
SROOedema peripheral · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release